Mechanistically, these variable outcomes of CCR5 deficiency in infectious diseases have been largely attributed to its regulatory effect on trafficking of leukocytes, including NK, CD4, CD8, and CD4+Foxp3+ Treg cells to the site of infection as a consequence of the elevated immunopathology. The gene discussed is CCR5; the disease is infectious disease.